These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 24384119)

  • 21. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
    Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
    Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps.
    Emblem KE; Nedregaard B; Nome T; Due-Tonnessen P; Hald JK; Scheie D; Borota OC; Cvancarova M; Bjornerud A
    Radiology; 2008 Jun; 247(3):808-17. PubMed ID: 18487536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Data-driven grading of brain gliomas: a multiparametric MR imaging study.
    Caulo M; Panara V; Tortora D; Mattei PA; Briganti C; Pravatà E; Salice S; Cotroneo AR; Tartaro A
    Radiology; 2014 Aug; 272(2):494-503. PubMed ID: 24661247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel method for analyzing DSCE-images with an application to tumor grading.
    Slotboom J; Schaer R; Ozdoba C; Reinert M; Vajtai I; El-Koussy M; Kiefer C; Zbinden M; Schroth G; Wiest R
    Invest Radiol; 2008 Dec; 43(12):843-53. PubMed ID: 19002056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
    Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
    Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
    Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of multiparametric 3-T MRI for glioma characterization.
    Roy B; Gupta RK; Maudsley AA; Awasthi R; Sheriff S; Gu M; Husain N; Mohakud S; Behari S; Pandey CM; Rathore RK; Spielman DM; Alger JR
    Neuroradiology; 2013 May; 55(5):603-13. PubMed ID: 23377234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New similarity search based glioma grading.
    Haegler K; Wiesmann M; Böhm C; Freiherr J; Schnell O; Brückmann H; Tonn JC; Linn J
    Neuroradiology; 2012 Aug; 54(8):829-37. PubMed ID: 22160184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric Analysis of Permeability and ADC Histogram Metrics for Classification of Pediatric Brain Tumors by Tumor Grade.
    Vajapeyam S; Brown D; Johnston PR; Ricci KI; Kieran MW; Lidov HGW; Poussaint TY
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):552-557. PubMed ID: 29301780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Glioma Grading With Inflow-Based Vascular-Space-Occupancy MRI: A Preliminary Study at 3T.
    Li X; Liao S; Hua J; Guo L; Wang D; Xiao X; Zhou J; Liu X; Tan Y; Lu L; Xu Y; Wu Y
    J Magn Reson Imaging; 2019 Dec; 50(6):1817-1823. PubMed ID: 30932289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.
    Conte GM; Altabella L; Castellano A; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Caulo M; Falini A; Anzalone N
    Eur Radiol; 2019 Jul; 29(7):3467-3479. PubMed ID: 30972545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.
    Falk A; Fahlström M; Rostrup E; Berntsson S; Zetterling M; Morell A; Larsson HB; Smits A; Larsson EM
    Neuroradiology; 2014 Dec; 56(12):1031-8. PubMed ID: 25204450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T2*-correction in dynamic contrast-enhanced MRI from double-echo acquisitions.
    Kleppestø M; Larsson C; Groote I; Salo R; Vardal J; Courivaud F; Bjørnerud A
    J Magn Reson Imaging; 2014 May; 39(5):1314-9. PubMed ID: 24123598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
    Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.